Unichem Laboratories Ltd. Quarter 4 and FY 2013-14 – Financial

Mumbai, Maharashtra, India- Business Wire India 
REVENUE 
The Company's standalone income from operations stood at Rs. 1,044.17 crs for
year ending March 31, 2014 as against Rs. 1,005.21 crs recorded in the same
period of previous year, reflecting a growth of 3.9 %.
The Company's consolidated income from operations stood at Rs. 1133.44 crs for
year ending March 31, 2014 as against Rs. 1080.80 crs recorded in the same
period of previous year, reflecting a growth of 4.87 %.  
PBT & PAT 
Standalone Profit Before Tax excluding Exceptional Items (Gain) for the year
ended March 31, 2014 stood at Rs. 178.82 crs as compared to Rs. 162.44 crs in
the same period last year. The Net Profit excluding Exceptional Items (Gain) for
the year ended March 31, 2014 stood at Rs. 135.82 crs as against Rs. 129.59 crs
in the same period last year. Net Profit margins excluding Exceptional Items
(Gain) stood at 13 % as against 12.9% of the previous year.
Consolidated Profit Before Tax excluding Exceptional Items (Gain) for the year
ended March 31, 2014 stood at Rs. 171.16 crs as compared to Rs. 146.07 crs in
the same period last year. The Net Profit excluding Exceptional Items (Gain) for
the year ended March 31, 2014 stood at Rs. 128.16 crs as against Rs. 113.22 crs
in the same period last year. Net Profit margins excluding Exceptional Items
(Gain) stood at 11.31% as against % 10.48% of the previous year.
The  stand alone EPS-Diluted excluding exceptional items (Gain) for the year
ended March 31, 2014 stood at Rs. 14.94 (corresponding period in the previous
year stood at Rs. 14.29).
The  consolidated  EPS-Diluted excluding exceptional items (Gain) for the year
ended March 31, 2014 stood at Rs. 14.10 (corresponding period in the previous
year stood at Rs. 12.48).
Exceptional  item net of tax amounting to Rs. 41.1 crs  represents profit on
sale of Company's manufacturing unit at SEZ, Indore and amortization of
intangible assets due to change in their estimated useful life. 
Dividend 
During the year, the Company has paid an interim dividend of Rs. 4/- (200%) per
equity share of face value of Rs.2/-. Further the Board of Directors at its
meeting held on May 10, 2014 has recommended a final dividend of Rs.4/- (200%),
making it total dividend of Rs.8/- (400%) for the year ended 31st March 2014.
Previous year dividend,   Rs. 4.50/- (225%).   
About Unichem Laboratories Limited 
Unichem Laboratories Limited is an International, integrated, specialty
pharmaceutical Company. It manufactures and markets a large basket of
pharmaceutical formulations as branded generics as well as generics in India and
several other markets across the world. In India, the Company is a leaded in
niche areas of cardiology, neurology and other orthopedics and anti-infectives.
The Company has strong skills in product development, process chemistry and
manufacturing of complex API as well as dosage forms. 
More information about the Company can be found at www.unichemlabs.com 
Media Contact Details 
Rakesh Parikh, Unichem Laboratories Limited, +91 (22) 66888414,
rparikh@unichemlabs.com 
Monish Shah, Unichem Laboratories Limited, +91 (22) 66888509,
monish.shah@unichemlabs.com 
Contributed via: Bloomberg Publisher WEB Service 
Provider ID: a5322962eea940418bcb40bbe305d7b9 
-0- May/12/2014 08:31 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.